ADJUNCTIVE USE OF ANTIBIOTICS IN PERIODONTAL THERAPY

Yıl 2015, Cilt: 49 Sayı: 3, 55 - 62, 21.10.2015

Ece Barça Ece Barça Emine Çifçibaşı Emine Çifçibaşı Serdar Çintan

https://doi.org/10.17096/jiufd.90144

Öz

Periodontal diseases are infectious diseases with a mixed microbial aetiology and marked inflammatory response leading to destruction of underlying tissue. Periodontal therapy aims to eliminate pathogens associated with the disease and attain periodontal health. Periodontitis is generally treated by nonsurgical mechanical debridement and regular periodontal maintenance care. Periodontal surgery may be indicated for some patients to improve access to the root surface; however, mechanical debridement alone may not be helpful in all cases. In such cases, adjunctive systemic antibiotic therapy remains the treatment of choice. It can reach microorganisms at the base of the deep periodontal pockets and furcation areas via serum, and also affects organisms residing within gingival epithelium and connective tissue. This review aims to provide an update on clinical issues regarding when and how to prescribe systemic antibiotics in periodontal therapy. The points discussed are the mode of antibiotic action, susceptible periodontal pathogens, antibiotic dosage, antibiotic use in treatment of periodontal disease, and mechanism of bacterial resistance to each antibiotic.

Anahtar Kelimeler

Systemic antibiotics; periodontal disease; treatment; aggressive periodontitis; chronic periodontitis

Periodontal Tedavide Kullanılan Antibiyotikler

Öz

Periodontal hastalıklar periodontal dokuların
doku yıkımına yol açan, karışık mikrobiyal etyolojisi
ve belirgin inflamatuvar yanıt ile karakterize
enfeksiyöz hastalıklardır. Periodontal tedavinin
amacı, hastalık ile ilişkili patojenlerin ortadan
kaldırılması ve periodontal sağlığın elde edilmesidir.
Periodontitis tedavisi genellikle cerrahi olmayan
mekanik debridman ve düzenli periodontal bakım
ile yapılır. Periodontal cerrahi bazı hastalarda kök
yüzeyine erişimi artırmak için endike olabilir; ancak,
yalnız mekanik debridman tüm durumlarda yarar
sağlamayabilir. Bu tür durumlarda, ilave antibiyotik
tedavisi düşünülebilir. Böylece, serum ile derin
periodontal cepler ve furkasyon alanlarının tabanında
mikroorganizmalara ulaşım ve aynı zamanda dişeti
epiteli ve bağ dokusu içinde bulunan organizmalara
etki sağlanır. Bu derlemede, periodontal hastalıkta
ne zaman ve hangi durumlarda sistemik antibiyotik
reçete edilmesi gerektiği üzerine güncel klinik
yaklaşımlar değerlendirilmiştir. Etki mekanizmaları,
duyarlı periodontal patojenler, dozaj, periodontal
hastalıkların tedavisinde kullanımı ve her antibiyotik
için bakteri direnç mekanizması tartışılmıştır.

Anahtar Kelimeler

Sistemik antibiyotikler, periodontal hastalık, tedavi, agresif periodontitis, kronik periodontitis

Kaynakça

• Saglie FR, Carranza FA Jr, Newman MG, Cheng L, Lewin KJ. Identification of tissue-invading bacteria in human periodontal disease. J Periodontol Res 1982;17(5):452–455.
• Marsh PD. Dental plaque: biological significance of a biofilm and community life-style. J Clin Periodontol 2005;32(Suppl 6):7–15.
• Eick S, Seltmann T, Pfister W. Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - an in vitro study. J Clin Periodontol 2004;31(5):376–383.
• Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005;43(11):5721-5732.
• Walker CB. The acquisition of antibiotic resistance in the periodontal microflora. Periodontol 2000 1996;10:79-88.
• Slots J, Rams TE. New views on periodontal microbiota in special patient categories. J Clin Periodontol 1991;18(6):411-420.
• Schenkein HA, Van Dyke TE. Early-onset periodontitis: systemic aspects of etiology and pathogenesis. Periodontol 2000 1994;6(1):7-25.
• Johnson BD, Engel D. Acute necrotizing ulcerative gingivitis. A review of diagnosis, etiology and treatment. J Periodontol 1986;57(3):141-150.
• Slots J, Rams TE. Antibiotics in periodontal therapy: advantages and disadvantages. J Clin Periodontol 1990;17(7 Pt 2):479-493.
• Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol 2003;8(1):115-181.
• Pallasch TJ. Pharmacokinetic principles of antimicrobial therapy. Periodontol 2000 1996;10(1):5-11.
• van Winkelhoff AJ, Rams TE, Slots J. Systemic antibiotic therapy in periodontitis. Periodontol 2000 1996;10(1):45-78.
• Socransky SS, Haffajee AD. Dental biofilms: difficult therapeutic targets. Periodontol 2000 2002;28(1):12-55.
• Van Winkelhoff AJ, Van der Velden U, Clement M, De Graaff J. Intra-oral distribution of black-pigmented Bacteriodes species in periodontitis patients. Oral Microbiol Immunol 1988;3(2):83-85.
• Walker CB. Selected antimicrobial agents: mechanism of action, side effects and drug interactions. Periodontol 2000 1996;10(1):12-28.
• Loesche WJ, Grossman N, Giordano J. Metronidazole in periodontitis (IV). The effect of patient compliance on treatment parameters. J Clin Periodontol 1993;20(2):96-104.
• Pavicic MJ, van Winkelhoff AJ, de Graaff J. In vitro susceptibilities of Actinobacilus actinomycetemcomitans to a number of antimicrobial combinations. Antimicrob Agents Chemother 1992;36(12):2634-2638.
• Slots J, Schonfeld SE. Actinobacillus actinomycetemcomitans in localized juvenile periodontitis. In: Hamada S, Holt SC, McGhee, JR, (Ed). Periodontal disease: pathogens& host immune responses. Tokyo: Quintessence Publishing Co.;1991,p.53-64.
• Goodson JM. Antimicrobial strategies for treatment of periodontal diseases. Periodontol 2000 1994;5(1):142-68.
• -
• Herrera D, Alonso B, Leon R, Roldan S, Sanz M. Antimicrobial therapy in periodontitis: the use of systemic antimicrobials against the subgingival biofilm. J Clin Periodontol 2008;35(8 Suppl):45-66.
• Herrera D, Sanz M, Jepsen S, Needleman I, Roldan S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planning in periodontitis patients. J Clin Periodontol 2002;29(Suppl 3):136-159.
• Lindhe J, Palmer R. Group C summary. J Clin Periodontol 2002;29(Suppl 3):160-162.
• Sanz M, Teughels W. Innovations in non-surgical periodontal therapy: Consensus Report of the Sixth European Workshop on Periodontology. J Clin Periodontol 2008;35(8 Suppl):3-7.
• Sampaio E, Rocha M, Figueiredo LC, Faveri M, Duarte PM, Gomes Lira EA, Feres M. Clinical and microbiological effects of azithromycin in the treatment of generalized chronic periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol 2011;38(9):838–846.
• Silva MP, Feres M, Sirotto TA, Soares GM, Mendes JA, Faveri M, Figueiredo LC. Clinical and microbiological benefits of metronidazole alone or with amoxicillin as adjuncts in the treatment of chronic periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol 2011;38(9):828–837.
• Mestnik MJ, Feres M, Figueiredo LC, Duarte PM, Lira EA, Faveri M. Short-term benefits of the adjunctive use of metronidazole plus amoxicillin in the microbial profile and in the clinical parameters of subjects with generalized aggressive periodontitis. J Clin Periodontol 2010;37(4):353–365.
• Yek EC, Cintan S, Topcuoglu N, Kulekci G, Issever H, Kantarci A. Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis. J Periodontol 2010;81(7):964–974.
• Griffiths GS, Ayob R, Guerrero A, Nibali L, Suvan J, Moles DR, Tonetti MS. Amoxicillin and metronidazole as an adjunctive treatment in generalized aggressive periodontitis at initial therapy or re-treatment: a randomized controlled clinical trial. J Clin Periodontol 2011;38(1):43–49.
• Guerrero A, Griffiths GS, Nibali L, Suvan J, Moles DR, Laurell L, Tonetti MS. Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol 2005;32(10):1096–1107.
• Heller D, Varela VM, Silva-Senem MX, Torres MC, Feres-Filho EJ, Colombo AP. Impact of systemic antimicrobials combined with anti-infective mechanical debridement on the microbiota of generalized aggressive periodontitis: a 6-month RCT. J Clin Periodontol 2011;38(4):355–364.
• Varela VM, Heller D, Silva-Senem MX, Torres MC, Colombo AP, Feres-Filho EJ. Systemic antimicrobials adjunctive to a repeated mechanical and antiseptic therapy for aggressive periodontitis: a 6-month randomized controlled trial.
• J Periodontol 2011;82(8):1121–1130.
• Aimetti M, Romano F, Guzzi N, Carnevale G. Full-mouth disinfection and systemic antimicrobial therapy in generalized aggressive periodontitis: a randomized, placebo-controlled trial. J Clin Periodontol 2012;39(3):284–294.
• Bonito AJ, Lux L, Lohr KN. Impact of local adjuncts to scaling and root planing in periodontal disease therapy: a systematic review. J Periodontol 2005;76(8):1227–1236.
• Pradeep AR, Sagar SV, Daisy H. Clinical and microbiologic effects of subgingivally delivered 0.5% azithromycin in the treatment of chronic periodontitis. J Periodontol 2008;79(11):2125-2135.
• Oteo A, Herrera D, Figuero E, O'Connor A, Gonzalez I, Sanz M. Azithromycin as an adjunct to scaling and root planing in the treatment of Porphyromonas gingivalis-associated periodontitis: a pilot study. J Clin Periodontol 2010;37(11):1005–1015.
• Onan U, Isik G, Firatli E. Periodontal tedavide kullanılan kemoterapötikler II: antibiyotikler, antibakteriyel ajanlar ve hassasiyet giderici ilaçlar. İstanbul Üniv Diş Hek Fak Derg 1992;26(1):42-47.